Page 36 - Read Online
P. 36

Page 214                      Walker. Neuroimmunol Neuroinflammation 2020;7:194-214  I  http://dx.doi.org/10.20517/2347-8659.2020.09

               105.  Liu Y, Walter S, Stagi M, Cherny D, Letiembre M, et al. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer’s amyloid
                   peptide. Brain 2005;128:1778-89.
               106.  Melief J, Sneeboer MAM, Litjens M, Ormel PR, Palmen SJMC, et al. Characterizing primary human microglia: a comparative study with
                   myeloid subsets and culture models. Glia 2016;64:1857-68.
               107.  Mizee MR, Miedema SSM, van der Poel M, Adelia Schuurman KG, van Strien ME, et al. Isolation of primary microglia from the human
                   post-mortem brain: effects of ante- and post-mortem variables. Acta Neuropathol Commun 2017;5:16.
               108.  Beschorner R, Nguyen TD, Gozalan F, Pedal I, Mattern R, et al. CD14 expression by activated parenchymal microglia/macrophages and
                   infiltrating monocytes following human traumatic brain injury. Acta Neuropathol 2002;103:541-9.
               109.  Walker DG, Tang TM, Mendsaikhan A, Tooyama I, Serrano GE, et al. Patterns of expression of purinergic receptor P2RY12, a putative
                   marker for non-activated microglia, in aged and Alzheimer’s disease brains. Int J Mol Sci 2020;21.
               110.  Zotova E, Bharambe V, Cheaveau M, Morgan W, Holmes C, et al. Inflammatory components in human Alzheimer’s disease and after
                   active amyloid-beta42 immunization. Brain 2013;136:2677-96.
               111.  Gomez-Nicola D, Boche D. Post-mortem analysis of neuroinflammatory changes in human Alzheimer’s disease. Alzheimers Res Ther
                   2015;7:42.
               112.  Hendrickx DAE, van Eden CG, Schuurman KG, Hamann J, Huitinga I. Staining of HLA-DR, Iba1 and CD68 in human microglia reveals
                   partially overlapping expression depending on cellular morphology and pathology. J Neuroimmunol 2017;309:12-22.
               113.  Satoh J, Kino Y, Asahina N, Takitani M, Miyoshi J, et al. TMEM119 marks a subset of microglia in the human brain. Neuropathology
                   2016;36:39-49.
               114.  Gonzalez Ibanez F, Picard K, Bordelau M, Sharma K, Bisht K, et al. Immunofluorescence staining using IBA1 and TMEM119 for
                   microglial density, morphology and peripheral myeloid cell infiltration analysis in mouse brain. J Vis Exp 2019; doi: 10.3791/60510.
               115.  van Wageningen TA, Vlaar E, Kooij G, Jongenelen CAM, Geurts JJG, et al. Regulation of microglial TMEM119 and P2RY12
                   immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment. Acta Neuropathol
                   Commun 2019;7:206.
               116.  Mildner A, Huang H, Radke J, Stenzel W, Priller J. P2Y12 receptor is expressed on human microglia under physiological conditions
                   throughout development and is sensitive to neuroinflammatory diseases. Glia 2017;65:375-87.
               117.  Walker DG, Dalsing-Hernandez JE, Campbell NA, Lue LF. Decreased expression of CD200 and CD200 receptor in Alzheimer’s disease:
                   a potential mechanism leading to chronic inflammation. Exp Neurol 2009;215:5-19.
               118.  Koning N, van Eijk M, Pouwels W, Brouwer MSM, Voehringer D, et al. Expression of the inhibitory CD200 receptor is associated with
                   alternative macrophage activation. J Innate Immun 2010;2:195-200.
               119.  Lyons A, Downer EJ, Crotty S, Nolan YM, Mills KHG, et al. CD200 ligand receptor interaction modulates microglial activation in vivo
                   and in vitro: a role for IL-4. J Neurosci 2007;27:8309-13.
               120.  Koning N, Swaab DF, Hoek RM, Huitinga I. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central
                   nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions. J Neuropathol Exp Neurol 2009;68:159-67.
               121.  Melief J, Koning N, Schuurman KG, Van De Garde MDB, Smolders J, et al. Phenotyping primary human microglia: tight regulation of
                   LPS responsiveness. Glia 2012;60:1506-17.
               122.  Pey P, Pearce RKB, Kalaitzakis ME, Griffin WST, Gentleman SM. Phenotypic profile of alternative activation marker CD163 is different
                   in Alzheimer’s and Parkinson’s disease. Acta Neuropathol Commun 2014;2:21.
               123.  Roberts ES, Masliah E, Fox HS. CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE). J Neuropathol
                   Exp Neurol 2004;63:1255-64.
               124.  Darmanis S, Gallant CJ, Marinescu VD, Niklasson M, Segerman A, et al. Simultaneous multiplexed measurement of RNA and proteins in
                   single cells. Cell Rep 2016;14:380-9.
               125.  Genshaft AS, Li S, Gallant CJ, Darmanis S, Prakadan SM, et al. Multiplexed, targeted profiling of single-cell proteomes and
                   transcriptomes in a single reaction. Genome Biol 2016;17:188.
               126.  Morrison LE, Lefever MR, Behman LJ, Leibold T, Roberts EA, et al. Brightfield multiplex immunohistochemistry with multispectral
                   imaging. Lab Invest 2020; doi: 10.1038/s41374-020-0429-0.
               127.  Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci 2016;19:987-91.
   31   32   33   34   35   36   37   38   39   40   41